Markets Businessinsider

Published October 8, 2026

Clearmind Announces Patent Publication in Japan Covering Treatment for Neurological ...

Read the full story at Markets Businessinsider

(Nasdaq: CMND) (the “Company”), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic -derived neuroplastogen for.